AeroSafe Global is revolutionizing the pharmaceutical supply chain through its proprietary “Cold Chain as a Service” (CCaaS) model, providing an end-to-end ecosystem that ensures the safe delivery of temperature-sensitive therapies to 80 countries. By integrating advanced packaging technology—leveraged by organizations like NASA—with their AI-driven Delivery Intelligence Navigator™, they offer the predictive visibility and real-time data integration required to safeguard life-saving treatments. Beyond logistics, the company is a leader in sustainability, with a full-cycle reuse program that reduces carbon emissions by 65% and landfill waste by 90% compared to traditional EPS solutions. Their commitment to “life-changing” logistics ensures that whether it’s a vaccine or a personalized immunotherapy, the integrity of every shipment is guaranteed for the patients who need them most.
MassBio Member Spotlight: AeroSafe Global
Location: 460 Buffalo Road, Suite 200, Rochester, NY 14611
Business type: Biopharmaceutical Logistics / Cold Chain as a Service (CCaaS)
Leadership: Tessa Paolini | Vice President of Strategic Accounts
Website: AeroSafeGlobal.com
